pregabalin and Migraine-with-Aura

pregabalin has been researched along with Migraine-with-Aura* in 1 studies

Other Studies

1 other study(ies) available for pregabalin and Migraine-with-Aura

ArticleYear
Chronic pregabalin treatment protects against spreading depolarization and alters hippocampal synaptic characteristics in a model of familial hemiplegic migraine-type 1.
    Molecular brain, 2023, Nov-03, Volume: 16, Issue:1

    Familial hemiplegic migraine type-1 (FHM-1) is a form of migraine with aura caused by mutations in the P/Q-type (Cav2.1) voltage-gated calcium channel. Pregabalin, used clinically in the treatment of chronic pain and epilepsy, inhibits P/Q-type calcium channel activity and recent studies suggest that it may have potential for the treatment of migraine. Spreading Depolarization (SD) is a neurophysiological phenomenon that can occur during migraine with aura by propagating a wave of silenced neuronal function through cortex and sometimes subcortical brain structures. Here, utilizing an optogenetic stimulation technique optimized to allow for non-invasive initiation of cortical SD, we demonstrate that chronic pregabalin administration [12 mg/kg/day (s.c.)] in vivo increased the threshold for cortical spreading depolarization in transgenic mice harboring the clinically-relevant Ca

    Topics: Animals; Hippocampus; Mice; Mice, Transgenic; Migraine Disorders; Migraine with Aura; Pregabalin

2023